The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 9
- 6 new, 3 renewals
- Median first-year cost
- $224,999
- $2,839,569 in all
- Institutions
- 7
- 7 contact PIs
Awards by fiscal year
6
0
3
0
0
0
0
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- HALCYON BIOMEDICAL, INC.2
- SILVER LAKE RESEARCH CORPORATION2
- BIOMEDOMICS, INC.1
- CORRELIA BIOSYSTEMS, INC.1
- DAKTARI DIAGNOSTICS, INC.1
and 2 other institutions
Most frequent study sections
- Special Emphasis Panel (ZHL1 CSR-C (M1))9
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2016 | Rapid LFIA blood test for SCD using highly specific monoclonal antibodies2R44HL123670-03 | Geisberg, Mark | SILVER LAKE RESEARCH CORPORATION, CA | First-year cost $500,000 | Study section ZHL1 |
| FY2016 | Developing a paper-based diagnostic test for sickle cell disease2R44HL123809-03 | Gifford, Sean | HALCYON BIOMEDICAL, INC., TX | First-year cost $497,654 | Study section ZHL1 |
| FY2016 | Sickle SCAN(R) - A rapid, qualitative test to aid in the diagnosis of sickle cell disorders2R44HL128670-02 | Kim, JasonYang, Xiaoxi | BIOMEDOMICS, INC., NC | First-year cost $496,086 | Study section ZHL1 |
| FY2014 | Electrokinetic Lateral Flow Tests for Rapid Point-of-Care Diagnosis of Sickle Cel1R43HL123846-01 | Apori, Akwasi | CORRELIA BIOSYSTEMS, INC., CA | First-year cost $225,000 | Study section ZHL1 |
| FY2014 | Self-assembling density gradients for sickle cell diagnosis in low resource areas1R43HL123818-01 | Fernandez-Suarez, Marta | DAKTARI DIAGNOSTICS, INC., MA | First-year cost $224,999 | Study section ZHL1 |
| FY2014 | Lateral Flow Immunoassay POC Device for the Diagnosis of Sickle Cell Disease1R43HL123443-01 | Qi, Hong | QOOLABS, INC., CA | First-year cost $224,998 | Study section ZHL1 |
| FY2014 | Developing a paper-based diagnostic test for sickle cell disease1R43HL123809-01 | Gifford, Sean | HALCYON BIOMEDICAL, INC., TX | First-year cost $224,885 | Study section ZHL1 |
| FY2014 | Antibody-based Point-of-Care Device for the Diagnosis of Sickle Cell Disease1R43HL123472-01 | Chimento, David P | ROCKLAND IMMUNOCHEMICALS, INC., PA | First-year cost $224,437 | Study section ZHL1 |
| FY2014 | Rapid LFIA blood test for SCD using highly specific monoclonal antibodies1R43HL123670-01 | Geisberg, Mark | SILVER LAKE RESEARCH CORPORATION, CA | First-year cost $221,510 | Study section ZHL1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.